Do I need to taper off citalopram (Selective Serotonin Reuptake Inhibitor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Citalopram: Yes, Gradual Discontinuation is Required

You should taper citalopram gradually rather than stopping abruptly to avoid potentially serious discontinuation symptoms. The FDA explicitly warns that "stopping citalopram tablets too quickly may cause serious symptoms including anxiety, irritability, high or low mood, feeling restless or changes in sleep habits, headache, sweating, nausea, dizziness, electric shock-like sensations, shaking, confusion" 1.

Why Tapering is Necessary

Citalopram, like other SSRIs with shorter half-lives, requires gradual tapering to minimize discontinuation symptoms 2. While one older study suggested minimal withdrawal phenomena with citalopram 3, more recent evidence and FDA labeling clearly establish that abrupt discontinuation causes significant problems:

  • Discontinuation symptoms are common and can be severe, including both somatic symptoms (dizziness, nausea, fatigue, flu-like symptoms, sensory disturbances) and psychological symptoms (anxiety, irritability, crying spells) 2
  • Abrupt cessation can cause sustained hypertension in addition to typical withdrawal symptoms, potentially requiring medical intervention 4
  • The FDA mandates discussing tapering with your healthcare provider before stopping citalopram 1

Recommended Tapering Approach

Reduce the dose hyperbolically (by percentage of current dose) rather than linearly, tapering slowly over weeks to months down to very small doses:

  • Reduce by 10-25% of the current dose every 1-2 weeks as a starting framework 2
  • For patients on citalopram long-term (>1 year), consider slower tapers of 10% per month 5
  • Each reduction should be a percentage of the current dose, not the original dose, to prevent disproportionately large final reductions 5
  • Taper to doses much lower than minimum therapeutic doses before complete cessation, as hyperbolic tapering reduces serotonin transporter occupancy linearly and minimizes withdrawal 6

Critical Pitfall to Avoid

Never use alternate-day dosing when tapering citalopram. Dosing every other day causes pronounced increases in receptor occupancy variation and dramatically increases withdrawal risk, even at low doses 7. This common practice should be avoided entirely 7.

Managing the Taper

The taper rate must be determined by your tolerance to withdrawal symptoms, not a rigid schedule 5:

  • Pauses in the taper are acceptable and often necessary when withdrawal symptoms emerge 5
  • If moderate to severe symptoms occur, reinstitute the previous dose and slow the taper rate 2
  • Some patients may need tapers extending over many months to avoid debilitating symptoms 5
  • Monitor at least monthly during tapering, with more frequent contact during difficult phases 5

When to Seek Additional Support

Consider cognitive-behavioral therapy during the taper, as it increases success rates and helps manage anxiety related to discontinuation 8, 5. If you experience severe or persistent withdrawal symptoms despite slow tapering, consult your healthcare provider about additional supportive strategies or even slower taper rates 2.

Do not attempt to stop citalopram without first discussing a tapering plan with your healthcare provider 1. Misdiagnosing withdrawal symptoms as physical illness or depression relapse can lead to unnecessary testing and treatment 2.

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

The safety and tolerability of citalopram.

International clinical psychopharmacology, 1996

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.